Home
About
Overview
Sharing Data
ORCID
Help
History (30)
Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulations.
Seroconversion
Safely Returning America to Work Part II: Industry-Specific Guidance.
Gonzalez, Ernesto
The safety of rosiglitazone in the treatment of type 2 diabetes.
See All 30 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The safety of rosiglitazone in the treatment of type 2 diabetes.
Singh S, Loke YK. The safety of rosiglitazone in the treatment of type 2 diabetes. Expert Opin Drug Saf. 2008 Sep; 7(5):579-85.
View in:
PubMed
subject areas
Blood Glucose
Cardiovascular Diseases
Clinical Trials as Topic
Diabetes Mellitus, Type 2
Fractures, Bone
Heart Failure
Humans
Hypoglycemic Agents
Myocardial Infarction
Risk Factors
Thiazolidinediones
authors with profiles
Sonal Singh MD, MPH